Disordered expression of inhibitory receptors on the NK1-type natural killer (NK) leukaemic cells from patients with hypersensitivity to mosquito bites

Clinical and Experimental Immunology

Volumn 120, Issue 3, 2000, Pages 413-419

  Seo, N ^b   Tokura, Y ^c   Ishihara, S ^a   Takeoka, Y ^a   Tagawa, S ^a   Takigawa, M ^c  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NONE

Author keywords

CD94; HLA E; Hypersensitivity to mosquito bites; NK cell; NKG2

Indexed keywords

CD94 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; MESSENGER RNA;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; CASE REPORT; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; HYPERSENSITIVITY; INSECT BITE; LEUKEMIA CELL; LYMPHOCYTE ACTIVATION; NATURAL KILLER CELL; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANIMALS; ANTIGENS, CD; ANTIGENS, CD94; CELLS, CULTURED; CULICIDAE; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HUMANS; HYPERSENSITIVITY; INSECT BITES AND STINGS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-2; JAPAN; KILLER CELLS, NATURAL; LECTINS, C-TYPE; MEMBRANE GLYCOPROTEINS; RECEPTORS, IMMUNOLOGIC; RECEPTORS, MITOGEN;

EID: 0034041606     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01253.x     Document Type: Article

References (29)

1. 1 Tokura Y, Tamura Y, Takigawa M, Koide M, Satoh T, Sakamoto T, Horiguchi D, Yamada M. Severe hypersensitivity to mosquito bites associated with natural killer cell lymphocytosis. Arch Dermatol 1990; 126:362-8.
2. 2 Ishihara S, Ohshima K, Tokura Y et al. Hypersensitivity to mosquito bites conceals clonal lymphoproliferation of Epstein-Barr viral DNA-positive natural killer cells. Jpn J Cancer Res 1997; 88:82-87.
3. 3 Mizuki M, Ueda S, Tagawa S et al. Natural killer cell-derived large granular lymphocyte lymphoma of lung developed in a patient with hypersensitivity to mosquito bites and reactivated Epstein-Barr virus infection. Am J Hematol 1998; 59:309-15.
4. 4 Tokura Y, Ishihara S, Ohshima K, Hidano A, Koide M, Seo N, Takigawa M. Severe mosquito bite hypersensitivity, natural killer cell leukaemia, latent or chronic active Epstein-Barr virus infection and hydroa vacciniforme-like eruption. Br J Dermatol 1998; 138:905-6.
5. 5 Kos FJ, Engleman EG. Immune regulation: a critical link between NK cells and CTLs. Immunol Today 1996; 17:174-6.
6. b molecules expressed on Th2-type γδ T and γβ T cells coinfiltrating in early B16 melanoma lesions. J Immunol 1998; 161:4138-45.
7. 7 Seo N, Tokura Y. Down-regulation of innate and acquired anti-tumor immunity by bystander γδ and γβ T lymphocytes with Th2 or Tr1 cytokine profile. J Interferon Cytokine Res 1999; 19:555-61.
8. 8 Seo N, Tokura Y, Takigawa M, Egawa K. Depletion of IL-10-and TGF-β-producing regulatory γδ T cells by administering a daunomycin-conjugated specific mAb in early tumor lesions augments the activity of CTLs and NK cells. J Immunol 1999; 163:242-9.
9. 9 Peritt D, Robertson S, Gri G, Showe L, Aste-Amezaga M, Trinchieri G. Differentiation of human NK cells into NK1 and NK2 subsets. J Immunol 1998; 161:5821-4.
10. 10 Long EO, Burshtyn DN, Clark WP, Peruzzi M, Rajagopalan S, Rojo S. Wagtmann N, Winter CC. Killer cell inhibitory receptors: diversity, specificity, and function. Immunol Rev 1997; 155:135-44.
11. 11 Lanier LL. NK cell receptors. Ann Rev Immunol 1998; 16:359-93.
12. 12 Vetvicka V, Hanikyrova M, Vetvickova J, Ross GD. Regulation of CR3 (CD1 1b/CD18)-dependent natural killer (NK) cell cytotoxicity by tumour target cell MHC class I molecules. Clin Exp Immunol 1999; 115:229-35.
13. 13 Bakker AB, Phillips JH, Figdor CG, Lanier LL. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, γδ T cells, and antigen-specific CTL. J Immunol 1998; 160:5239-45.
14. 14 Kim J, Chwae YJ, Kim MY, Choi IH, Park JH, Kim SJ. Molecular basis of HLA-C recognition by p58 natural killer cell inhibitory receptors. J Immunol 1997; 159:3875-82.
15. 15 Peruzzi M, Wagtmann N, Long EO. A p70 killer cell inhibitory receptor specific for several HLA-B allotypes discriminates among peptides bound to HLA-B*2705. J Exp Med 1996; 184:1585-90.
16. 16 Boyington JC, Riaz AN, Patamawenu A, Coligan JE, Brooks AC, Sun PD. Structure of CD94 reveals a novel C-type lectin fold: implications for the NK cell-associated CD94/NKG2 receptors. Immunity 1999; 10:75-82.
17. 17 Lee N, Llano M, Carretero M, Ishitani A, Navarro F, Lopez-Botet M, Geraghty DE. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci USA 1998; 95:5199-204.
18. 18 Lanier LL, Corliss B, Wu J, Phillips JH. Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity 1998; 8:693-701.
19. 19 Tagawa S, Hatakeyama M, Shibano M, Taniguchi T, Kitani T. The expression of the p75 subunit of interleukin 2 receptor in Tac negative leukemic cells of two patients with large granular lymphocytic leukemia. Blood 1988; 71:1161-4.
20. 20 Seo N, Tokura Y, Matsumoto K, Furukawa F, Takigawa M. Tumor-specific cytotoxic T lymphocyte activity in Th2-type Sezary syndrome: its enhancement by interferon-gamma (IFN-γ) and IL-12 and fluctuations in association with disease activity. Clin Exp Immunol 1998; 112:403-9.
21. 21 Houchins JP, Yabe T, McSherry C, Bach FH. DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J Exp Med 1991; 173:1017-20.
22. 22 Fiszer D, Ulbrecht M, Fernandez N, Johnson JP, Weiss EH, Kurpisz M. Analysis of HLA class Ib gene expression in male gametogenic cells. Eur J Immunol 1997; 27:1691-5.
23. 23 Koller BH, Geraghty DE, Shimizu Y, DeMars R, Orr HT. HLA-E. A novel HLA class I gene expressed in resting T lymphocytes. J Immunol 1988; 141:897-904.
24. 24 Seo N, Egawa K. Suppression of cytotoxic T lymphocyte activity by γ/ δ T cells in tumor-bearing mice. Cancer Immunol Immunother 1995; 40:358-66.
25. 25 Perez-Villar J, Melero I, Rodriguez A et al. Functional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen. J Immunol 1995; 154:5779-88.
26. 26 O'Callaghan CA, Bell JI. Structure and function of the human MHC class Ib molecules HLA-E, HLA-F and HLA-G. Immunol Rev 1998; 163:129-38.
27. 27 Mizuno S, Trapani JA, Koller BH, Dupont B, Yang SY. Isolation and nucleotide sequence of a cDNA clone encoding a novel HLA class I gene. J Immunol 1988; 140:4024-30.
28. 28 Boyson JE, McAdam SN, Gallimore A, Golos TG, Liu X, Gotch FM, Hughes AL, Watkins DI. The MHC E locus in macaques is polymorphic and is conserved between macaques and humans. Immunogenet 1995; 41:59-68.
29. 29 Kundu N, Fulton AM. Interleukin-10 inhibits tumor metastasis, downregulates MHC class I, and enhances NK lysis. Cell Immunol 1997; 180:55-61.